The study is evaluating the efficacy, safety and tolerability of NT100, an investigational medicine, in women who have had repeated IVF failures despite having good-quality embryos.
NT100 is a novel treatment that is being evaluated to determine if it improves your chances of getting pregnant after IVF. For more information about NT100, visit www.noratherapeutics.com.
You may be eligible for the Thrive-IVF Research Study if you:
· Are between 21 and 38 years of age
· Have had three or more failed IVF cycles that included transfer of good-quality embryos (at least 2 of these involving the transfer of fresh embryos)
Qualified participants will receive study-related tests and procedures at no cost, including:
· An IVF cycle, including procedures and medications
· Study medication
If you are interested in learning more about the Thrive-IVF study, please visit www.ivfresearchstudy.com and visit their Facebook Page. The participating offices are listed below.